United States Metabolic Disorder Drugs Research
8 comprehensive market analysis studies and research reports on the United States Metabolic Disorder Drugs sector, offering an overview with historical data since 2019 and forecasts up to 2030. This includes a detailed market research of 92 companies, enriched with industry statistics, insights, and a lot more.
Healthcare
Categories
8 Healthcare Reports
Categories
Showing 8 of 8 results in Metabolic Disorder Drugs
Hyperkalemia Treatment Market
CAGR: 16.79%
Study Period: 2019 - 2030
Country Covered: United States
Major Players:Sanofi, Perrigo Company, CSL Behring, AstraZeneca, Ardelyx
Gaucher Disease Drugs Market
CAGR: 2.10%
Study Period: 2019 - 2030
Country Covered: United States
Major Players:Sanofi, Pfizer, Takeda Pharmaceuticals, Janssen, Protalix BioTherapeutics
Hyperphosphatemia Treatment Market
CAGR: 3.67%
Study Period: 2019 - 2030
Country Covered: United States
Major Players:Sanofi, Astellas Pharma, Ardelyx, Alebund Pharmaceuticals, Kyowa Kirin
Postoperative Nausea And Vomiting Market
CAGR: 5.48%
Study Period: 2019 - 2030
Country Covered: United States
Major Players:Heron Therapeutics, Helsinn Healthcare, Teva Pharmaceutical Industries, Novartis, Eisai
United States Cardiometabolic Fixed-Dose Combinations Market
CAGR: 3.74%
Study Period: 2019 - 2030
Country Covered: United States
Major Players:Merck, AstraZeneca, Pfizer, Novo Nordisk, Sanofi
Fibrate Drugs Market
CAGR: 5.25%
Study Period: 2019 - 2030
Country Covered: United States
Major Players:Sun Pharmaceuticals Industries, Abbott Laboratories, Lupin, Cipla, Abbvie
Lysosomal Storage Disease Treatment Market
CAGR: 8.21%
Study Period: 2021 - 2030
Country Covered: United States
Major Players:Pfizer, Takeda Pharmaceuticals, Sanofi, BioMarin, Johnson & Johnson
Global Phenylketonuria Treatment Market
CAGR: 9.38%
Study Period: 2019 - 2030
Country Covered: United States
Major Players:Biomarin Pharmaceutical, Vitaflo International (Nestlé Health Science), Nutricia Advanced Medical Nutrition, APR Applied Pharma Research (PKU GOLIKE), Orpharma Pty Ltd
Yay! You have seen it all
CONTACT US
When decisions matter, industry leaders turn to our analysts. Let’s talk.
